MedTrace Logo

Optical Coherence Tomography in Acute Coronary Syndrome

NCT03129503 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 414

Last updated 2019-07-23

No results posted yet for this study

Summary

The OPTICO-ACS- study program - combining for the first time in vivo characterization of the ACS-causing "culprit lesion" by intracoronary imaging technique with optical coherence tomography (OCT) and molecular analysis of immune-cells derived from the culprit coronary thrombus and biochemical analyses in patients with acute-coronary-syndrome (ACS).

Conditions

  • Acute Coronary Syndrome
  • STEMI - ST Elevation Myocardial Infarction
  • NSTEMI - Non-ST Segment Elevation MI
  • Atherosclerosis, Coronary

Sponsors & Collaborators

  • Berlin Institut of Health (BIH), Germany

    collaborator UNKNOWN

  • Charite University, Berlin, Germany

    lead OTHER

Principal Investigators

  • David M Leistner, MD · Charite - University Medicine Berlin - Department for cardiology

  • Ulf Landmesser, MD · Charite - University Medicine Berlin - Department for cardiology

Eligibility

Min Age
18 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2017-04-28
Primary Completion
2024-03-31
Completion
2024-03-31

Countries

  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03129503 on ClinicalTrials.gov